Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s10549-008-9905-8, but it redirected us to https://link.springer.com/article/10.1007/s10549-008-9905-8. The analysis below is for the second page.

Title[redir]:
Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast | Breast Cancer Research and Treatment
Description:
Background Loss of the chromosomal material at 16q is the most frequent genetic event in invasive and in situ (LCIS) lobular carcinoma of the breast. However, the smallest region of overlap at 16q is not restricted to just the CDH1 locus harbouring E-cadherin, suggesting that neighbouring genes might be involved in the development and progression of these tumours. Potential novel tumour suppressor genes (TSG) at 16q include CCCTC-binding factor (CTCF), Decreased Expression in Renal and Prostate Cancer (DERPC) and Dipeptidase 1 (DPEP1). The aim of this study is to assess the expression of these genes in LCIS and compare them with normal breast, using CDH1 as a control, in order to evaluate their role as TSGs. Methods Cells from LCIS cases and normal breast lobules were microdissected and expression of target genes were quantified using real-time PCR. In addition, immunohistochemistry (IHC) for E-cadherin and CTCF was performed on paraffin processed LCIS (n = 49) and normal breast cases. Results All LCIS showed negative expression of E-cadherin. Similar to CDH1, CTCF and DPEP1 gene expression was significantly lower in LCIS cases compared with normal cases (P < 0.05). CTCF IHC expression showed significant reduction in LCIS compared to normal parenchymal cells. However, there was no difference in expression of DERPC between LCIS and normal breast tissue. Conclusions In addition to CDH1, loss of CTCF and DPEP1 gene expression suggest they are possible TSG in breast cancer and may, similar to CDH1, be potentially utilised as markers of predisposition of women diagnosed with LCIS.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't tell how the site generates income.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

breast, google, scholar, article, pubmed, cancer, cas, expression, ctcf, lobular, carcinoma, gene, ecadherin, genes, situ, lcis, res, loss, invasive, cdh, analysis, green, ellis, normal, access, cell, pathol, privacy, cookies, content, research, chromosome, dpep, factor, ductal, biol, lobanenkov, data, publish, search, andrew, rakha, paish, powe, cases, cletonjansen, human, van, mutations, zinc,

Topics {✒️}

month download article/chapter mammalian c-myc oncogenes laser capture microdissection transcription factor ctcf real-time pcr analysis mccarty ks sr paraffin-embedded biopsies full article pdf walborg ef jr privacy choices/manage cookies zinc finger mutations real-time pcr methylation profiles cell growth inhibition thick tissue specimens normal breast tissue invasive breast cancer candidate gene located human e-cadherin lobular breast cancer e-cadherin alterations dpep1 gene expression paraffin processed lcis tumour suppressor genes atypical ductal hyperplasia european economic area columnar cell lesions amo-takyi bk comparative genomic hybridization de leeuw wj filippova gn morse hc 3rd glutathione-degrading enzymes blanchette-mackie ej monoclonal antireceptor antibodies formalin-fixed barcellos-hoff mh ortiz-de-solorzano ter haar nt e-cadherin inactivation kidney complementary dnas subtractive hybridization approach normal breast lobules molecular medical sciences invasive tubular carcinoma ctcf gene mutations conditions privacy policy atypical lobular hyperplasia scott-conner ce reis-filho js

Questions {❓}

  • Cleton-Jansen AM (2002) E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast
         description: Background Loss of the chromosomal material at 16q is the most frequent genetic event in invasive and in situ (LCIS) lobular carcinoma of the breast. However, the smallest region of overlap at 16q is not restricted to just the CDH1 locus harbouring E-cadherin, suggesting that neighbouring genes might be involved in the development and progression of these tumours. Potential novel tumour suppressor genes (TSG) at 16q include CCCTC-binding factor (CTCF), Decreased Expression in Renal and Prostate Cancer (DERPC) and Dipeptidase 1 (DPEP1). The aim of this study is to assess the expression of these genes in LCIS and compare them with normal breast, using CDH1 as a control, in order to evaluate their role as TSGs. Methods Cells from LCIS cases and normal breast lobules were microdissected and expression of target genes were quantified using real-time PCR. In addition, immunohistochemistry (IHC) for E-cadherin and CTCF was performed on paraffin processed LCIS (n = 49) and normal breast cases. Results All LCIS showed negative expression of E-cadherin. Similar to CDH1, CTCF and DPEP1 gene expression was significantly lower in LCIS cases compared with normal cases (P < 0.05). CTCF IHC expression showed significant reduction in LCIS compared to normal parenchymal cells. However, there was no difference in expression of DERPC between LCIS and normal breast tissue. Conclusions In addition to CDH1, loss of CTCF and DPEP1 gene expression suggest they are possible TSG in breast cancer and may, similar to CDH1, be potentially utilised as markers of predisposition of women diagnosed with LCIS.
         datePublished:2008-01-23T00:00:00Z
         dateModified:2008-01-23T00:00:00Z
         pageStart:59
         pageEnd:66
         sameAs:https://doi.org/10.1007/s10549-008-9905-8
         keywords:
            Lobular carcinoma in situ
            E-cadherin
            CCCTC-binding factor
            Dipeptidase 1
            Laser microdissection
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9905-8/MediaObjects/10549_2008_9905_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9905-8/MediaObjects/10549_2008_9905_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9905-8/MediaObjects/10549_2008_9905_Fig3_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:113
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Andrew R. Green
               affiliation:
                     name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Sophie Krivinskas
               affiliation:
                     name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Young
               affiliation:
                     name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emad A. Rakha
               affiliation:
                     name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Claire Paish
               affiliation:
                     name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Desmond G. Powe
               affiliation:
                     name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ian O. Ellis
               affiliation:
                     name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast
      description: Background Loss of the chromosomal material at 16q is the most frequent genetic event in invasive and in situ (LCIS) lobular carcinoma of the breast. However, the smallest region of overlap at 16q is not restricted to just the CDH1 locus harbouring E-cadherin, suggesting that neighbouring genes might be involved in the development and progression of these tumours. Potential novel tumour suppressor genes (TSG) at 16q include CCCTC-binding factor (CTCF), Decreased Expression in Renal and Prostate Cancer (DERPC) and Dipeptidase 1 (DPEP1). The aim of this study is to assess the expression of these genes in LCIS and compare them with normal breast, using CDH1 as a control, in order to evaluate their role as TSGs. Methods Cells from LCIS cases and normal breast lobules were microdissected and expression of target genes were quantified using real-time PCR. In addition, immunohistochemistry (IHC) for E-cadherin and CTCF was performed on paraffin processed LCIS (n = 49) and normal breast cases. Results All LCIS showed negative expression of E-cadherin. Similar to CDH1, CTCF and DPEP1 gene expression was significantly lower in LCIS cases compared with normal cases (P < 0.05). CTCF IHC expression showed significant reduction in LCIS compared to normal parenchymal cells. However, there was no difference in expression of DERPC between LCIS and normal breast tissue. Conclusions In addition to CDH1, loss of CTCF and DPEP1 gene expression suggest they are possible TSG in breast cancer and may, similar to CDH1, be potentially utilised as markers of predisposition of women diagnosed with LCIS.
      datePublished:2008-01-23T00:00:00Z
      dateModified:2008-01-23T00:00:00Z
      pageStart:59
      pageEnd:66
      sameAs:https://doi.org/10.1007/s10549-008-9905-8
      keywords:
         Lobular carcinoma in situ
         E-cadherin
         CCCTC-binding factor
         Dipeptidase 1
         Laser microdissection
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9905-8/MediaObjects/10549_2008_9905_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9905-8/MediaObjects/10549_2008_9905_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-008-9905-8/MediaObjects/10549_2008_9905_Fig3_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:113
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Andrew R. Green
            affiliation:
                  name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Sophie Krivinskas
            affiliation:
                  name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Young
            affiliation:
                  name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emad A. Rakha
            affiliation:
                  name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Claire Paish
            affiliation:
                  name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Desmond G. Powe
            affiliation:
                  name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ian O. Ellis
            affiliation:
                  name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:113
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Andrew R. Green
      affiliation:
            name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Sophie Krivinskas
      affiliation:
            name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Peter Young
      affiliation:
            name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Emad A. Rakha
      affiliation:
            name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:E. Claire Paish
      affiliation:
            name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Desmond G. Powe
      affiliation:
            name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:Ian O. Ellis
      affiliation:
            name:University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Nottingham, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(178)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

5.15s.